Featured Product
This Week in Quality Digest Live
FDA Compliance Features
Etienne Nichols
What’s the difference?
Liza Dzhezhora
How to ensure the integration of IoMT devices in your practice
Del Williams
Options to address the risk of combustible dust explosions for NFPA 61 compliance
Doug Folsom
Unpatched vulnerabilities will become increasingly susceptible to cyberattacks
Del Williams
Mitigate risk, prevent safety issues by utilizing closed conveyor systems designed with sanitation in mind

More Features

FDA Compliance News
Creates one of the most comprehensive regulatory SaaS platforms for the industry
Company’s first funding round will be used to accelerate product development for its QMS and MES SaaS offerings
Showcasing tech, solutions, and services at Gulfood Manufacturing 2022
Easy, reliable leak testing with methylene blue
Now is not the time to skip critical factory audits and supply chain assessments
Google Docs collaboration, more efficient management of quality deviations
Delivers time, cost, and efficiency savings while streamlining compliance activity
First trial module of learning tool focuses on ISO 9001 and is available now
Free education source for global medical device community

More News

Quality Digest

FDA Compliance

PhRMA President Issues Counterfeit Drug Warning

Published: Tuesday, June 21, 2005 - 22:00

The recent publication of a magazine article about the growing black market for counterfeit drugs prompted the president and CEO of the Pharmaceutical Research and Manufacturers of America to issue a warning. The article, published in the June 20 issue of Forbes magazine, details the growing counterfeit drug trade, especially as it affects Medicare recipients. The article discusses substandard medication and the ability of scammers to convince vulnerable senior citizens that cheap know-off medication is just as good as the real thing.

PhRMA’s president and CEO Billy Tauzin says that American pharmaceutical companies need to continue work with U.S. law enforcement to ensure counterfeit drugs don’t make it into the United States.

“These reports are additional proof that opposing dangers ideas like drug importation is the right thing to do,” Tauzin says. “The American people should heed these warnings rather than support unsafe legislation that would allow for the importation of counterfeit drugs from abroad.”

“Overwhelmingly, Americans take for granted the safety and purity of the medicines they receive through legal regulated sources; that is as is should be,” Tauzin continues. “America’s drug safety network will be compromised if we open our borders to drugs from other countries whose regulatory systems are not as strong as ours.”

For more information, visit www.phrma.org.


About The Author

Quality Digest’s picture

Quality Digest

For 40 years Quality Digest has been the go-to source for all things quality. Our newsletter, Quality Digest, shares expert commentary and relevant industry resources to assist our readers in their quest for continuous improvement. Our website includes every column and article from the newsletter since May 2009 as well as back issues of Quality Digest magazine to August 1995. We are committed to promoting a view wherein quality is not a niche, but an integral part of every phase of manufacturing and services.